July 1 - September 30, 2009

1. Section 8 of the PM(NOC) Regulations – No Claim for Disgorgement or Accounting of Profits
   Apotex Inc. v. Eli Lilly Canada Inc. 2009 FC 378 (Tabib, P.)
    
2. Prohibition Order Issued for One of Two Patents on Formulations of Clarithromycin
   Abbott Laboratories v. Canada (Health), 2009 FC 648 (Heneghan, J.)
    
3. Exaggerations in Patent Specification Lead to Invalidity
   Ratiopharm Inc. v. Pfizer Limited, 2009 FC 711 (Hughes J.)
    
4. Court Quashes PMPRB’s Requirement to Include Third Party Rebates in Patent Pricing
   Pfizer Canada Inc. v. Canada (Attorney General), 2009 FC 719, (Mactavish, J.)
    
5. Invalidity Allegations with Respect to Controlled Release Oxycodone Compositions Patent Found Not Justified
   Purdue Pharma v. Pharmascience Inc. 2009 FC 726 (Harrington, J.)
    
6. Right of Reply When Evidence Not Anticipated
   AstraZeneca Canada Inc., AstraZeneca AB and Shionogi Seiyaku Kabushiki Kaisha v. Novopharm Limited and The Minister of Health 2009 FC 902 (Aalto, P.)
    
7. The Potential Cost and Tactical Consequences of a Motion to Strike
   Michael J. Culhane v. Philip Andrew Croucher d.b.a. Electrocution Technical Publishers et al. 2009 FC 769 (Hughes, J.)
     
8. Court to Consider Prothonotary’s Order De Novo
   Janssen-Ortho Inc. v. Apotex Inc. 2009 FC 783 (Hughes J.)
    
9. Assessment of Costs – Invitation for Submissions as to Costs is not a Rule 400 Exercise of Discretion by the Court and Will Not Trigger Payment of Interest
   Eli Lilly and Company v. Novopharm Limited and Registrar of Trade-Marks 2009 FC 797 (Charles E. Stinson, Assessment Officer)
    
10. Irreparable Harm Test No Different for Copyright, Trade-mark or Passing Off
    Western Steel and Tube Ltd. v. Erickson Manufacturing Ltd. 2009 FC 791 (Snider J.)
     
11. No Contempt for the Fault of Another Person
    Canadian Private Copying Collective v. Yeung 2009 FC 800 (Martineau, J.)
     
12. Costs Should Reflect the Reality of the Reality of the Demands of Litigation
    AstraZeneca AB v. Apotex Inc. 2009 FC 822 (Stinson, Assessment Officer)
     
13. Pillow Fights!
    Sissel-Online Ltd. v. Sissel Handels GMBH, 2009 FC 827 (Hansen J.)
     
14. Interrogatoires au préalable: questions à répondre et documents à produire
    Eurocopter v. Bell Helicopter Textron Canada limitée 2009 CF 836
     
15. Court Refuses to Stay Order Dismissing Prohibition Proceeding Pending Appeal
    Janssen-Ortho Inc. v. Apotex Inc. et al 2009 FCA 250 (Sharlow J.A.)
     
16. Appeal from Prothonotary’s Order Consolidating Applications Dismissed
    Janssen-Ortho v. Apotex Inc.  2009 FC 866 (Kelen, J.)
     
17. Summary Judgment Against Company and its President Finds “Deliberate, Willful and Knowing” Infringement
    2045978 Ontario Inc., c.o.b. Chaps the Original v. Chaps Aldershot Inc. c.o.b. Lezley’s Chaps and Kevin Saunders 2009 FC 872 (Zinn, J.)
     
18. Court Awards Summary Judgment in Copyright Infringement Action
    Koslowski v. Hogan Scott Courrier (Geeks Galore Computer Center), 2009 FC 883 (Kelen, J)
     
19. Direction to Attend Not to be Used as a Discovery Mechanism
    Simpson Strong-Tie Co. v. Peak Innovations Inc., 2009 FCA 266 (Sexton, Blais and Layden-Stevenson JJ.A.)
     
20. Evidence of Actual Costs Incurred or Specific Directions from the Federal Court is Required in Assessing Costs
    See You In – Canadian Athletes Fund Corporation v. Canadian Olympic Committee, 2009 FC 908 (Bruce Preston, Assessment Officer)
     
21. No Double Patenting, Claims Invalid, Patent Prohibition Orders Not Set Aside, No Section 8 Damages
    Aventis-Pharma Inc. v. Pharmascience Inc. 2009 FC 915 (Zinn J.)
     
22. PM(NOC) – Reply Evidence Must Address New Facts and Arguments Raised by the Other Party
    Merck-Frosst – Schering Pharma GP and Shering Corporation. v. Novopharm and Minister of Health, 2009 FC 914 (Zinn J)
     
23. Federal Court Awards Costs “In Any Event of the Cause”
    Underwriters Laboratories Inc. v. San Francisco Gifts Ltd. et al. 2009 FC 909 (Hugessen, J.)
     
24. Delay in Filing Statement of Claim Allowed
    Princess Group Inc. and Princess Auto Ltd. v. Canadian Standards Association 2009 FC 926 (Harrington, J.)
     
25. Punitive Damages Warranted Where Infringing Activity Persists Despite Warning
    Microsoft Corporation v. 1276916 Ontario Ltd. 2009 FC 849 (Mandamin, J.) 
     
26. Registrar Ordered to Reinstate Registration on New Evidence of a Licensing Agreement
    3082833 Nova Scotia Company v. Lang Michener LLP and Registrar of Trade-marks 2009 FC 928 (Kelen J.)
     
27. Late Amendments Revising the Quantum of Damages Sought Upwardly Are Allowable
    Apotex Inc. v. Wellcome Foundation Limited, 2009 FC 949 (Mr. Justice Roger T. Hughes)
     
28. Application for Judicial Review Dismissed
    Sanofi-Aventis Canada Inc. v. Attorney General of Canada 2009 FC 965
      
29. Motion for a Stay by a Statutory Authority Requires Factual Evidence
    Commissioner of Patents (AG Canada) v. Sydnet H. Belzberg  2009 FCA 275 (Sharlow J.A.)
     
30. Costly Behaviour
    2045978 Ontario Inc., c.o.b. Chaps the Original v. Chaps Aldershot Inc. c.o.b. Lezley’s Chaps and Kevin Saunders 2009 FC 981 (Zinn, J.).